迈博药业有限公司（股票代码：02181）于2026年3月3日发布截至2026年2月28日的股份变动月报表。公告显示，公司本月无新增发行、购回或注销股份，各类股本保持不变。
迈博药业有限公司注册股本为50,000,000,000股，每股面值0.0001美元，总注册股本约5,000,000美元。截至2月28日，公司已发行股份数量维持在4,124,080,000股，未持有任何库藏股份。公告同时确认其公众持股量满足相关上市规则的最低要求。
期权激励方面，公司现有股权激励计划下授出的股份期权数为72,670,876份，与上月持平。本月未有行使或失效记录，亦无因此发行或转让新股。
整体而言，截至2026年2月28日，公司股本数量未发生变化。公告由公司秘书曾浩贤先生签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.